Quantifying long-term wound healing

What are the long-term wound-healing changes in clear corneal cataract incisions? US researchers used Fourier-domain optical coherence tomography (OCT) in a series of eyes that had phacoemulsification one day to 180 months previously. The incision midpoint was measured with OCT. They found that Descemet’s membrane detachment occurred in 37.1 per cent of eyes one day postoperatively and in 4.5 per cent of eyes at one to three months (P=.005). It was absent after three months. Posterior wound gape appeared in 85.7 per cent of eyes at one day and in 31.8 per cent at one to three months (P<.001); it was absent after three months. Posterior wound retraction appeared in 33.3 per cent of eyes at two to three weeks, in 75.0 per cent at one to three years, and in 90.5 per cent after three years (P<.001). The mean wound retraction was 120 μm, which was 7.5 per cent of the radial incision length.
L Wang et al., JCRS, “Healing changes in clear corneal cataract incisions evaluated using Fourier-domain optical coherence tomography,†660-665.
Latest Articles
Making Female Leadership More than a Moment
A remarkable global confluence of women in key positions.
ESCRS Talks Technology at AAO
Europe adopts technological advances, US still waiting for lenses and lasers.
Sorting Out Simultaneous Vision IOLs
The ESCRS Eye Journal Club discuss a new landmark paper on IOL classification and the need for harmonisation of terminology for presbyopic IOLs.
Big Advantages to Small-Aperture IOLs
Small-aperture IOLs offer superior image quality with increased range of focus.
Prioritising Self-Care
Benefits of maintaining physical, emotional, and mental health extend beyond the personal sphere.
Valuing Clinical Trial Design
How inclusivity and diversity can enhance scientific accuracy in research.
Knowing Iris Repair: Using Iridodiathermy in Iris Surgery
Prepare for decentred pupils and uneven irides in multiple situations.
Neuroprotectant Treatment for MacTel Type 2
Intravitreal implant releasing ciliary neurotrophic factor found safe and effective in pivotal trials.